1Tripathi RC, Parapuram SK, Tripathi BJ, Zhong Y, Chalam KV. Corticosteroids and glaucoma risk[J]. Drugs Aging 1999;15(6):439-450.
2Weinreb RN, Polansky JR, Kramer SG, Baxter JD. Acute effects of dexamethasone on intraocular pressure in glaucoma[J]. Invest Ophthalmol Vis Sci 1985; 26: 170-175.
3Hermande MR, Eenk EJ, Weinstein BI. Glucocorticoid target cells in human outflow pathway[J]. Invest Ophthalmol Vis Sci 1983; 24: 1612-1616.
4Encio IJ, Detera-Wadleigh SD. The genomic structure of the human glucocorticoid receptor[J]. Biol Chem 1991; 266: 7182-7188.
5Galigniana MD, Radanyi C, Rendir JM, Housley PR, Pratt WB. Evidence that the peptidylprolyl isomerase domain of the hsp90-binding immunophilin FKBP52 is involved in both dynein interaction and glucocorticoid receptor movement to the nucleus[J]. Biol Chem 2001; 276(8): 14884-14889.
6Wordinger RJ, Clark AF.Effects of glucocorticoids on the trabecular meshwork: towards a better understanding of glaucoma[J]. Prog Retinal Eye Res 1999; 18(5): 629-667.
7Johnson D, Gottanka J, Flugel C, Hoffmann F,Futa R,Lutjen-Dreldl E,et al. Ultrastructural changes in the trabecular meshwork of human eyes treated with glucocorticoids[J]. Arch Ophthalmol 1997; 115: 375-383.
8Potan JM,Canals M,Costa J,Merindano MD,Ruano D. Ultrastructural characteristics of glaucomatous trabeculer meshwork[J]. Arch Soc Esp Oftalmol 2000;75(1):21-28.
9Engelbrecht-Schnur S, Siegner A, Prehm P, Lutjen-Drecoll E. Dexamethasone treatment decreases hyaluronan-formation by primate trabecular meshwork cells in vitro[J] . Exp Eye Res 1997; 64: 539-543.
10Zhan GL, Miranda OC, Bito LZ. Sreroid glaucoma: corticosteroid-induced ocular hypertension in cats[J] . Exp Eye Res 1992; 54: 211-218.
